TongliBio
Latest round
- Angel
Last raised
- Apr 2017
Total raised
- $1.4M
Investors
- 1
About TongliBio
Established in 2012 and based in Suzhou, China, TongliBio is a biotechnology company that provides drugs for zoonotic infectious diseases. In September 2020, the firm closed a strategic investment. Mingxin Qian, the founder of the company, has worked in Bristol-Myers Squibb, Genentech and other companies. The company focuses on the development of anthelmintic drugs for tropical infectious diseases and zoonosis. Its products include TL-010, TL-230 and TL-310.
Who invested in TongliBio
1 investor across 1 round
See all investors in TongliBio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Angel
Apr 8, 2017
Amount
$1.4M
Investors
Questions about TongliBio
Who invested in TongliBio?
TongliBio has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has TongliBio raised?
TongliBio has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did TongliBio last raise money?
TongliBio's most recent round on record is a Angel, in Apr 2017.
What does TongliBio do?
Established in 2012 and based in Suzhou, China, TongliBio is a biotechnology company that provides drugs for zoonotic infectious diseases.
Where is TongliBio headquartered?
TongliBio is headquartered in Suzhou, China.
Which VCs invest in companies like TongliBio?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back biotechnology companies at TongliBio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Angel
Raising like TongliBio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.